USFDA approves Eli Lilly's Trulicity (dulaglutide) for reduction in MACE in type 2 diabetes patient Medical Dialogues Bureau23 Feb 2020 12:00 PM ISTNew indication reflects a distinct patient population in the REWIND study, including primary people with multiple cardiovascular risk factors but...
Novo Nordisk wins EU panel's backing for key diabetes drug Ruby Khatun Khatun18 Dec 2017 10:30 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
FDA approves Novo Nordisk diabetes drug Ozempic Ruby Khatun Khatun6 Dec 2017 10:30 AM ISTThe U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...